+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli versus Klebsiella pneumoniae: Does type of germ really matter?



Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli versus Klebsiella pneumoniae: Does type of germ really matter?



Infection Control and Hospital Epidemiology 39(9): 1137-1138




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 064315970

Download citation: RISBibTeXText

PMID: 30041708

DOI: 10.1017/ice.2018.152


Related references

Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. Journal of Clinical Microbiology 42(1): 269-275, 2004

Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clinical Microbiology and Infection 10(8): 752-755, 2004

Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infection Control and Hospital Epidemiology 29(11): 1026-1034, 2008

Extended spectrum beta lactamase (ESBL) producing Escherichia coli and klebsiella pneumoniae in diabetic foot infection. Indian Journal of Medical Microbiology 26(3): 281-282, 2008

A comparison of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bloodstream infections in Alberta using a provincial surveillance system. Infection Control and Hospital Epidemiology 40(3): 388, 2019

Antibiogram and plasmid profiling of carbapenemase and extended spectrum Beta-lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Abeokuta, South western, Nigeria. African Health Sciences 13(4): 1091-1097, 2013

Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella pneumoniae: activity of single versus combination agents. Journal of Antimicrobial ChemoTherapy 51(3): 737-739, 2003

Epidemiology of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli in Japan: Characteristics of community-associated versus healthcare-associated ESBL E. coli. Journal of Infection and ChemoTherapy 23(2): 117-119, 2017

Resistance of Klebsiella pneumoniae strains producing and not producing ESBL (extended-spectrum beta-lactamase) type enzymes to selected non-beta-lactam antibiotics. Medical Science Monitor 8(3): Br100, 2002

Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia. Archives of Gerontology and Geriatrics 58(1): 105-109, 2014

Detection of Ctx-M gene in extended spectrum beta lactamase (Esbl) producing Escherichia coli and Klebsiella species of different hospitals. Bangladesh Journal of Medical Microbiology 4(2): 28-31, 2012

Prevalence and antibiogram of Extended Spectrum β-Lactamase (ESBL) producing Gram negative bacilli and further molecular characterization of ESBL producing Escherichia coli and Klebsiella spp. Journal of Clinical and Diagnostic Research 7(10): 2173-2177, 2013

Extended-spectrum beta-lactamase (ESBL) produced by Escherichia coli and Klebsiella pneumoniae isolated from Teikyou University Hospital--the first report. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 73(11): 1110-1115, 1999

Extended-spectrum beta-lactamase (ESBL) produced by Escherichia coli and Klebsiella pneumoniae isolated from Teikyo University Hospital--the second report. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 74(1): 24-29, 2000

Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectiveness. Journal of Infection 51(3): 211-217, 2005